Carl Zeiss Meditec saw a decline in revenue in its 2019-2020 fiscal year, down 8.5% to 1,335.5 million euros, due to the COVID-19 pandemic, according to a press release.
Revenue in the company’s ophthalmic devices strategic business unit decreased 7.3%, while the microsurgery strategic business unit decreased 11.7%.
In the Americas, revenue decreased 13.2%, with significant decreases in the United States and Brazil, which both experienced growth in the first 6 months of the fiscal year, the release said.
In the Europe, Middle East and Africa region, revenue decreased 13.1%, while revenue
Uncategorized